Rock Springs Capital Management LP Celldex Therapeutics, Inc. Transaction History
Rock Springs Capital Management LP
- $1.47 Billion
- Q2 2025
A detailed history of Rock Springs Capital Management LP transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Rock Springs Capital Management LP holds 812,653 shares of CLDX stock, worth $19.3 Million. This represents 1.12% of its overall portfolio holdings.
Number of Shares
812,653
Previous 812,653
-0.0%
Holding current value
$19.3 Million
Previous $14.7 Million
12.12%
% of portfolio
1.12%
Previous 0.88%
Shares
12 transactions
Others Institutions Holding CLDX
# of Institutions
198Shares Held
68.2MCall Options Held
219KPut Options Held
238K-
Kynam Capital Management, LP Princeton, NJ6.1MShares$145 Million14.83% of portfolio
-
Wellington Management Group LLP Boston, MA5.23MShares$125 Million0.02% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$112 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.96MShares$94.2 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.82MShares$90.9 Million0.01% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $1.11B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...